{
    "clinical_study": {
        "@rank": "16516", 
        "biospec_descr": {
            "textblock": "whole blood"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "Aim: The purpose of this study was to evaluate both the effects of ibuprofen and/or\n      acetaminophen for the acute treatment of primary migraine in children in or out prophylactic\n      treatment with magnesium.\n\n      Methods: The study had been approved by the Researchers Ethics Committee of the\n      \"Pugliese-Ciaccio\" Hospital (protocol number 720/2010; EUDRACT NUMBER 2012-005737-36) and\n      the  children ranging from the ages of 5 to 18 years with at least four attack/month of\n      primary migraine were enrolled. A Visual Analogical Scale was used to evaluate pain\n      intensity at the moment of admission to the study (start of the study) and every month up to\n      18 months later (end of the study)."
        }, 
        "brief_title": "Acetaminophen and Ibuprofen With and Without Magnesium and Primary Migraine in Childhood", 
        "completion_date": {
            "#text": "February 2012", 
            "@type": "Actual"
        }, 
        "condition": "Migraine", 
        "condition_browse": {
            "mesh_term": "Migraine Disorders"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Children with migraine without aura (MoA) of both sexes aged from 5 to 18 years, with at\n        least four attacks /month, were eligible for the study. MoA was diagnosed according to the\n        criteria for pediatric age of the International Classification of Headache Disorders\n        (IHS-2)\n\n        Exclusion Criteria:\n\n        Exclusion criteria were the following: mental retardation (IQ <70), genetic syndromes\n        (e.g., Down syndrome, Prader-Willi syndrome, fragile X syndrome), hypothyroidism,\n        psychiatric disorders (i.e.: schizophrenia, mood disorders, ADHD), neuromuscular\n        disorders, epilepsy, obesity (BMI>95 percentiles), liver or renal diseases,\n        gastrointestinal disorders such as peptic or duodenal ulcer, dyspepsia, or heartburn;\n        hypersensitivity to medication studies."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "5 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "we peformed a single blind study in outpatient children enrolled at the Pediatric\n        Unit-Pugliese Ciaccio Hospital in Catanzaro"
            }
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 19, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01756209", 
            "org_study_id": "Migraine2010"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Acetaminophen", 
                "Ibuprofen"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 19, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Catanzaro", 
                    "country": "Italy", 
                    "zip": "88100"
                }, 
                "name": "Pugliese Ciaccio Hospital"
            }
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_groups": "1", 
        "official_title": "The Effects of Acetaminophen and Ibuprofen With and Without Magnesium in the Treatment of Primary Migraine in Childhood", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The primary endpoint was when pain-relief took place and pain intensity differences from baseline (0 hour) to 3 hours after drug treatment. This measurement was defined as the AUC for the sum of the 2 measurements (pain relief and pain intensity difference) at each time point from 0 to 3 hours.", 
            "measure": "pain-relief", 
            "safety_issue": "No", 
            "time_frame": "3 and 18 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01756209"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Cantanzaro", 
            "investigator_full_name": "Luca Gallelli", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Cantanzaro", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Cantanzaro", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2010", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "18 Months", 
        "verification_date": "December 2012"
    }
}